NeurAxis, Inc. (NRXS) Stock Analysis — Probabli.AI
AI-powered analysis for NRXS (NeurAxis, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $7.61 · Market cap: $83.7M · AI outlook: Bullish
NeurAxis, Inc. has shown impressive short-term growth potential due to recent FDA approval and strategic partnerships. While some volatility and competition risks exist, the company's revenue trajectory and focus on transformative technology paint a strong growth picture for long-term investors.
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 25% · Bear 15%
- 1-year price estimates — P10: $6 / P50: $11 / P90: $16
- NeurAxis has shown impressive potential given its FDA approval and partnership announcement. The strong buy recommendation with a median target of $13 also highlights bullish sentiment, although the market still…
5-Year Outlook
- Bull 70% · Neutral 20% · Bear 10%
- 5-year price estimates — P10: $7 / P50: $21 / P90: $46
SWOT Highlights
- Strength: FDA approval of a new treatment
- Strength: High revenue growth potential
- Risk: Still not consistently profitable
- Risk: High competition in the medical devices sector
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
1 Wall Street analyst rate NRXS a STRONG BUY with a mean price target of $13.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
NRXS forecast details · NRXS sentiment details · NRXS insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.